Around 40% of the global population (3.1 billion people) experience migraine and headache disorders, making proper diagnosis and management critical for health. The Automatic Hematology Analyzer LMAHA-A100 supports laboratories in evaluating overall health through comprehensive blood testing. By integrating advanced technology, it aids clinicians in timely detection of underlying conditions that may contribute to headache and migraine episodes.